VEGF Receptor 2 (VEGFR2) Peptide
VEGFR2
Reactivité: Humain, Souris, Poisson zèbre (Danio rerio)
Hôte: Synthetic
BP
-
- Antigène Tous les produits VEGFR2/CD309 (VEGFR2)
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Type de proteíne
- Synthetic
- Origine
- Humain, Souris, Poisson zèbre (Danio rerio)
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-VEGFR2 Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Synonymes
- CD309 Peptide, FLK1 Peptide, VEGFR Peptide, VEGFR2 Peptide, 6130401C07 Peptide, Flk-1 Peptide, Flk1 Peptide, Krd-1 Peptide, Ly73 Peptide, VEGFR-2 Peptide, sVEGFR-2 Peptide, Vegfr-2 Peptide, FLK-1 Peptide, flk-1 Peptide, vegfr-2 Peptide, KDR Peptide, FLK/KDR Peptide, flk1 Peptide, flk1b Peptide, kdrb Peptide, si:busm1-205d10.1 Peptide, si:ch211-254j6.1 Peptide, si:ch211-278f21.4 Peptide, wu:fc31a09 Peptide, fk52c05 Peptide, flk Peptide, kdr Peptide, kdra Peptide, vegfr2 Peptide, vegfr4 Peptide, vegr2 Peptide, wu:fk52c05 Peptide, kinase insert domain receptor Peptide, kinase insert domain protein receptor Peptide, vascular endothelial growth factor receptor kdr-like Peptide, kinase insert domain receptor (a type III receptor tyrosine kinase) Peptide, kinase insert domain receptor like Peptide, KDR Peptide, Kdr Peptide, LOC100136647 Peptide, kdr Peptide, kdrl Peptide
- Sujet
- FLK1, VEGFR2, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309
- ID gène
- 3791
- UniProt
- P35968, P35918
-
Vous êtes ici:
